
KOD Valuation
Kodiak Sciences Inc
KOD Relative Valuation
KOD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KOD is overvalued; if below, it's undervalued.
Historical Valuation
Kodiak Sciences Inc (KOD) is now in the Fair zone, suggesting that its current forward PS ratio of 18.13 is considered Fairly compared with the five-year average of -6.77. The fair price of Kodiak Sciences Inc (KOD) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:18.12
Fair
-4.67
PE
1Y
3Y
5Y
Trailing
Forward
-3.69
EV/EBITDA
Kodiak Sciences Inc. (KOD) has a current EV/EBITDA of -3.69. The 5-year average EV/EBITDA is -5.57. The thresholds are as follows: Strongly Undervalued below -27.81, Undervalued between -27.81 and -16.69, Fairly Valued between 5.55 and -16.69, Overvalued between 5.55 and 16.67, and Strongly Overvalued above 16.67. The current Forward EV/EBITDA of -3.69 falls within the Historic Trend Line -Fairly Valued range.
-3.58
EV/EBIT
Kodiak Sciences Inc. (KOD) has a current EV/EBIT of -3.58. The 5-year average EV/EBIT is -4.51. The thresholds are as follows: Strongly Undervalued below -21.76, Undervalued between -21.76 and -13.14, Fairly Valued between 4.11 and -13.14, Overvalued between 4.11 and 12.73, and Strongly Overvalued above 12.73. The current Forward EV/EBIT of -3.58 falls within the Historic Trend Line -Fairly Valued range.
18.13
PS
Kodiak Sciences Inc. (KOD) has a current PS of 18.13. The 5-year average PS is 1.01. The thresholds are as follows: Strongly Undervalued below -8.43, Undervalued between -8.43 and -3.71, Fairly Valued between 5.73 and -3.71, Overvalued between 5.73 and 10.45, and Strongly Overvalued above 10.45. The current Forward PS of 18.13 falls within the Strongly Overvalued range.
-5.70
P/OCF
Kodiak Sciences Inc. (KOD) has a current P/OCF of -5.70. The 5-year average P/OCF is -8.05. The thresholds are as follows: Strongly Undervalued below -29.91, Undervalued between -29.91 and -18.98, Fairly Valued between 2.89 and -18.98, Overvalued between 2.89 and 13.82, and Strongly Overvalued above 13.82. The current Forward P/OCF of -5.70 falls within the Historic Trend Line -Fairly Valued range.
-4.49
P/FCF
Kodiak Sciences Inc. (KOD) has a current P/FCF of -4.49. The 5-year average P/FCF is -7.78. The thresholds are as follows: Strongly Undervalued below -30.88, Undervalued between -30.88 and -19.33, Fairly Valued between 3.77 and -19.33, Overvalued between 3.77 and 15.32, and Strongly Overvalued above 15.32. The current Forward P/FCF of -4.49 falls within the Historic Trend Line -Fairly Valued range.
Kodiak Sciences Inc (KOD) has a current Price-to-Book (P/B) ratio of 13.59. Compared to its 3-year average P/B ratio of 1.75 , the current P/B ratio is approximately 677.98% higher. Relative to its 5-year average P/B ratio of 3.33, the current P/B ratio is about 308.14% higher. Kodiak Sciences Inc (KOD) has a Forward Free Cash Flow (FCF) yield of approximately -12.11%. Compared to its 3-year average FCF yield of -87.49%, the current FCF yield is approximately -86.16% lower. Relative to its 5-year average FCF yield of -62.15% , the current FCF yield is about -80.51% lower.
13.59
P/B
Median3y
1.75
Median5y
3.33
-12.11
FCF Yield
Median3y
-87.49
Median5y
-62.15
Competitors Valuation Multiple
The average P/S ratio for KOD's competitors is 18.11, providing a benchmark for relative valuation. Kodiak Sciences Inc Corp (KOD) exhibits a P/S ratio of 18.13, which is 0.08% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of KOD increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of KOD in the past 1 year is driven by Unknown.
People Also Watch

LND
BrasilAgro - Companhia Brasileira de Propriedades Agricolas
3.720
USD
+0.54%

TERN
Terns Pharmaceuticals Inc
8.260
USD
+1.23%

NYXH
Nyxoah SA
5.190
USD
+3.18%

AMPX
Amprius Technologies Inc
14.090
USD
+14.65%

HLLY
Holley Inc
2.870
USD
-0.35%

JMIA
Jumia Technologies AG
10.910
USD
+0.74%

HOUS
Anywhere Real Estate Inc
10.050
USD
+3.61%

BMRC
Bank of Marin Bancorp
25.750
USD
-2.02%

ZEUS
Olympic Steel Inc
37.000
USD
+4.46%

HBCP
Home Bancorp Inc
53.150
USD
-1.19%
FAQ
Is Kodiak Sciences Inc (KOD) currently overvalued or undervalued?
Kodiak Sciences Inc (KOD) is now in the Fair zone, suggesting that its current forward PS ratio of 18.13 is considered Fairly compared with the five-year average of -6.77. The fair price of Kodiak Sciences Inc (KOD) is between to according to relative valuation methord.







